Organization Announcements

Organization Announcements
Editor’s Note:
Careful readers will note that the number and range of organizations now monitored in our Announcements section below has grown as the impacts of the pandemic have spread across global economies, supply chains and programmatic activity of multilateral agencies and INGOs.


Paul G. Allen Frontiers Group [to 3 Apr 2021] ess/
No new digest content identified.


BARDA – U.S. Department of HHS [to 3 Apr 2021]
March 31, 2021: HHS launches $500,000 contest for design of new, effective, comfortable masks for general public use
…, the Biomedical Advanced Research and Development Authority (BARDA) is collaborating with the National Institute for Occupational Safety and Health, part of the U.S. Centers for Disease Control and Prevention, on the personal use mask design challenge. NIOSH administers the nation’s respirator approval program.
The first phase of the challenge, which opens today, invites new mask designs that meet specific criteria and asks the submitter to describe how that design idea fits the criteria and solves the hurdles to mask wearing. Up to 10 winning ideas will be selected to split $100,000. Submissions are due by 5 p.m. EDT April 21, 2021…


BMGF – Gates Foundation [to 3 Apr 2021]
Press Releases and Statements
No new digest content identified.


Bill & Melinda Gates Medical Research Institute [to 3 Apr 2021]
The Bill & Melinda Gates Medical Research Institute is a non-profit biotech organization. Our mission is to develop products to fight malaria, tuberculosis, and diarrheal diseases—three major causes of mortality, poverty, and inequality in developing countries. The world has unprecedented scientific tools at its disposal; now is the time to use them to save the lives of the world’s poorest people
No new digest content identified.


CARB-X [to 3 Apr 2021]
03.30.2021  |
CARB-X is funding University of Oxford’s Jenner Institute to develop a new vaccine to prevent gonorrhea
CARB-X is awarding up to US$2 million to the Jenner Institute, part of the University of Oxford, UK, to develop a novel vaccine to prevent gonorrhea, a common sexually-transmitted bacterial infection that has developed resistance to most antibiotics. Under the award, the Institute would be eligible for up to $5.3 million more if the project progresses through certain project milestones, subject to available funding.


Center for Vaccine Ethics and Policy – GE2P2 Global Foundation [to 3 Apr 2021]
:: Past weekly editions of Vaccines and Global Health: The Week in Review are available here.


CEPI – Coalition for Epidemic Preparedness Innovations [to 3 Apr 2021]
Latest News
CEPI launches funding call to advance development of broadly protective coronavirus vaccines
:: Up to US$200 million in funding to be allocated for development of vaccines that provide broad protection against SARS-CoV-2 and betacoronaviruses.
:: R&D will focus on novel immunogens for use in vaccines that can elicit durable broadly protective immune responses.
:: Funding call forms part of CEPI’s longer term $3.5bn investment strategy, announced earlier in March, 2021, which is being activated now to mitigate the urgent threat posed by COVID-19.
31 Mar 2021

CEPI Board membership updates
30 Mar 2021
CEPI is pleased to announce that Professor Dr Veronika von Messling has been appointed to the Board where she will sit as an Investor representative. Dr von Messling replaces Dr Joachim Klein, who has stood down after 3 years of service.
Alongside her role on the Board, Dr von Messling will also join the Nominations, Compensation, Diversity and Inclusion committee.
Dr von Messling is Director General of the Life Science Division at the German Federal Ministry of Education and Research…


DARPA – Defense Advanced Research Projects Agency [to 3 Apr 2021
No new digest content identified.


Duke Global Health Innovation Center [to 3 Apr 2021]
No new digest content identified.


EDCTP [to 3 Apr 2021]
The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials
No new digest content identified.


Emory Vaccine Center [to 3 Apr 2021]
Vaccine Center News
No new digest content identified.


European Commission [to 3 Apr 2021]
Statement 31 March 2021
Statement of Commissioner Reynders on the referral of Poland to the European Court of Justice to protect independence of Polish judges and asks for interim measures

Press release 31 March 2021
Rule of Law: European Commission refers Poland to the European Court of Justice to protect independence of Polish judges and asks for interim measures
Today, the European Commission decided to refer Poland to the Court of Justice of the European Union regarding the law on the judiciary of 20 December 2019, which entered into force on 14 February 2020.

Press release 30 March 2021
Syrian crisis: €5.3 billion mobilised by donors for 2021 and beyond at 5th Brussels Conference
At the fifth Brussels Conference on ‘Supporting the future of Syria and the Region’ co-chaired today by the European Union and the United Nations, the international community pledged €5.3 billion for 2021 and beyond for Syria and the neighbouring countries hosting Syrian refugees.


European Medicines Agency [to 3 Apr 2021]
News & Press Releases
News: AstraZeneca COVID-19 vaccine: review of very rare cases of unusual blood clots continues (new)
PRAC, Last updated: 31/03/2021

News: EU recommendations for 2021-2022 seasonal flu vaccine composition (new)
Last updated: 30/03/2021


European Vaccine Initiative [to 3 Apr 2021]
Latest News
No new digest content identified.


FDA [to 3 Apr 2021]
Press Announcements /Selected Details
April 2, 2021 – Coronavirus (COVID-19) Update: April 2, 2021

March 30, 2021 – Coronavirus (COVID-19) Update: March 30, 2021


Fondation Merieux [to 3 Apr 2021]
News, Events
Mérieux Foundation co-organized event
Vaccine Acceptance webinars: managing vaccine misinformation in the midst of a pandemic
April 15, 2021 – Virtual Event


Gavi [to 3 Apr 2021]
News Releases
31 March 2021
Gavi and Save the Children form global partnership to immunise zero-dose and vulnerable children
:: The partnership will focus on reaching children who are currently receiving no routine vaccines and marginalised communities in line with Gavi’s vision to ‘leave no-one behind with immunisation’
:: In addition, the partnership will support equitable access to COVID-19 vaccines by engaging with community champions on joint activities
:: Anuradha Gupta: “A disproportionate number of children who are not receiving vaccines come from hard-to-reach areas including fragile and conflict settings which is why we’re delighted to partner with Save the Children whose worldwide network and deep expertise will enable us to reach them”

29 March 2021
United States to host launch event for Gavi COVAX AMC 2021 investment opportunity
:: The virtual event will bring together world leaders, the private sector, civil society, and key technical partners to galvanize resources and commitment to the Gavi COVAX Advance Market Commitment (AMC)
:: The event, featuring the Secretary of State and the USAID Administrator on behalf of the United States government, and Gavi Board Chair José Manuel Barroso, will take place on April 15
:: The Gavi COVAX AMC is a financing mechanism that supports access to COVID-19 vaccines for 92 lower-income economies


GHIT Fund [to 3 Apr 2021]
GHIT was set up in 212 with the aim of developing new tools to tackle infectious diseases that
March 31, 2021
GHIT Fund Announces New Investments: A Total of 2.3 Billion Yen in Drugs for Malaria, Tuberculosis, Chagas Disease and Visceral Leishmaniasis, Vaccine for Malaria and Diagnostics for Tuberculosis
… As of March 31, GHIT’s portfolio includes 57 ongoing projects, including 30 in discovery stages, 20 in preclinical and seven in clinical trials (Appendix 3). The total amount of investments since 2013 is 25.1 billion yen (US$236 million).


Global Fund [to 3 Apr 2021]
News & Stories
The Global Fund’s Sixth Partnership Forums Generate Recommendations for the Next Global Fund Strategy
01 April 2021
The Sixth Partnership Forums ended on 15 March, having convened approximately 350 representatives from across the Global Fund partnership in a series of engaging, inclusive and energetic discussions to contribute to the development of the next Global Fund Strategy…


Global Research Collaboration for Infectious Disease Preparedness [GloPID-R] [to 3 Apr 2021]
No new digest content identified.


Hilleman Laboratories [to 3 Apr 2021]
No new digest content identified.


Human Vaccines Project [to 3 Apr 2021]
No new digest content identified.


IAVI [to 3 Apr 2021]
April 2, 2021
Donor Spotlight: Government of India
IAVI recognizes the Government of India for their unwavering support of the development of safe, effective, accessible, preventive HIV vaccines and biomedical prevention products for use throughout the world.



International Coalition of Medicines Regulatory Authorities [ICMRA]
Selected Statements, Press Releases, Research
No new digest content identified.



International Generic and Biosimilar Medicines Association [IGBA]
Press Releases/Announcements
No new digest content identified.



Press Releases/Announcements
No new digest content identified.


IFRC [to 3 Apr 2021]
Selected Press Releases, Announcements
Statement on International Treaty on Pandemics “We need bold new solutions – both in international and domestic laws – to avoid the same mistakes”
Geneva, 30 March 2021 In response to a common call for an International Treaty on Pandemics by the WHO and world leaders today, Jagan Chapagain, Secretary General of the International Federation of Red Cross Red Crescent Societies, said: We are encouraged by this commitment from the WHO and world leaders today to develop a new treaty on pandemic prevention and response. The COVID-19 response has been hugely impaired by gaps in global cooperation and inequities affecting some of the most vulnerable of our societies. This treaty is an opportunity to address these for the next time.
“We need bold new solutions – both in international and domestic laws – to avoid the same mistakes. These must include a firm commitment to preparedness at all levels of society, including at the community level, and equitable access to testing, vaccines and treatment for all at greatest risk. We must also ensure that health and emergency staff and volunteers are supported to operate safely to provide life-saving aid, and access communities in need. And we must guard against the economic ruin of the poorest and most vulnerable as a result of pandemic responses.
“With our experience in supporting states to develop and implement disaster law and policy around the world, IFRC and its members stand ready to provide their expertise and advice to governments and to support such a treaty to not only be powerful on paper but transformative in reality.”


Institut Pasteur [to 3 Apr 2021]
No new digest content identified.


IRC International Rescue Committee [to 3 Apr 2021]
Media highlights [Selected]
Press Release
Statement from the International Rescue Committee on the Generation Equality Forum
April 1, 2021

Ethiopia: IRC statement on the killing of humanitarian aid workers
April 1, 2021

Press Release
Las continuas caravanas migrantes son síntomas de la emergencia en el norte de Centroamérica, advierte IRC
March 31, 2021

Press Release
Ongoing migrant caravans are symptoms of the emergencies in northern Central America, warns IRC
March 31, 2021

Press Release
México: Postura del IRC sobre la muerte de Victoria Salazar
March 30, 2021


IVAC [to 3 Apr 2021]
Updates; Events
Improving the Health of Women and Children in India
March 2021 A Director’s Message
On New Year’s Day in 2021, approximately 68,000 babies were born across India. Their mothers would have traversed the arduous journey of pregnancy to reach the miraculous day of their birth. How many of these babies will be alive and thriving by the end of the year 2021? About five decades ago, […]


IVI [to 3 Apr 2021]
Selected IVI News, Announcements, Events
International Vaccine Institute and Institut Pasteur Korea Sign MOU for Research and Development of Infectious Disease Therapeutics and Vaccines
April 1, 2021, GYEONGDO-DO and SEOUL, Korea – The International Vaccine Institute (IVI) and the Institut Pasteur Korea (IPK) signed a memorandum of understanding (MOU) for mutual collaboration in the research and development of therapeutics and vaccines for infectious diseases…
Towards the shared goal of improving public health, the IPK and IVI will promote research collaboration and information exchange, holding joint workshops and seminars to connect biomedical scientists and infectious disease experts of the two organizations and their partners worldwide.
In particular, the collaboration combines IPK’s research and technology in infectious disease and IVI’s capabilities and know-how in developing and designing new vaccines and in supporting clinical trials to accelerate new therapeutics and vaccine development. IPK and IVI have common fields of research interest in COVID-19, MERS, Dengue, TB, etc…


JEE Alliance [to 3 Apr 2021]
Selected News and Events
No new digest content identified.


Johns Hopkins Center for Health Security [to 3 Apr 2021]
Center News
No new digest content identified.


MSF/Médecins Sans Frontières [to 3 Apr 2021]
Latest [Selected Announcements
Democratic Republic of Congo
In DRC, measles is spreading and killing again in what seems to be a never-ending fight
Project Update 31 Mar 2021

Coronavirus COVID-19 pandemic
“Only vaccination will end the ferocious spread of COVID-19 in Iraq”
Op-Ed 31 Mar 2021

Sustainable solutions for children and adolescents at risk of drug-resistant tuberculosis
Project Update 30 Mar 2021


National Academy of Medicine – USA [to 3 Apr 2021]
Accessed 3 April 2021
Advancing Pandemic and Seasonal Influenza Vaccine Preparedness and Response
An International Committee will inform and facilitate efforts to advance global influenza pandemic preparedness. This International Committee will provide an iterative, interactive, multi-disciplinary, expert-informed process for assessing the global impact that capabilities, technologies, processes, and policies developed for COVID-19 could have on pandemic and seasonal influenza global preparedness and response, especially regarding vaccine development.
Upcoming Events:
:: Overview of Vaccine Science: Establishing Priorities to Improve Influenza Vaccines (April 15)
:: Major Barriers to Effective Global Coordination and Financing for Influenza Vaccination- Day 1 (April 9)
:: Major Barriers to Effective Global Coordination and Financing for Influenza Vaccination- Day 2 (April 16)
Past Events:
Overview of Vaccine Science: Existing Evidence and Lessons from COVID-19 (March 30)


National Vaccine Program Office – U.S. HHS [to 3 Apr 2021]
Upcoming Meetings/Latest Updates
No new digest content identified.


NIH [to 3 Apr 2021]
News Releases
NIH clinical trial evaluating Moderna COVID-19 variant vaccine begins
March 31, 2021 — Early-stage trial to evaluate safety and immunogenicity.

CDC and NIH bring COVID-19 self-testing to residents in two locales
March 31, 2021 — Participating households will receive free month-long supply of rapid tests aimed at reducing community transmission.

T cells recognize recent SARS-CoV-2 variants
March 30, 2021 — NIH research suggests protective effects of vaccination remain intact.


UN OCHA Office for the Coordination of Humanitarian Affairs [to 3 Apr 2021]
Press Releases
No new digest content identified.


PATH [to 3 Apr 2021]
Press Releases
No new digest content identified.


Sabin Vaccine Institute [to 3 Apr 2021]
Statements and Press Releases
No new digest content identified.


UNAIDS [to 3 Apr 2021]
Selected Press Releases/Reports/Statements
1 April 2021
President of Afghanistan declares ‘unwavering support’ for a People’s Vaccine for COVID-19

1 April 2021
New study recommends strategies to serve the under-protected Caribbean transgender community

31 March 2021
UNAIDS joins human rights community in mourning Christof Heyns, legal academic and expert

31 March 2021
(Wo)man in the Mirror: seeing your true self

30 March 2021
Solidarity fund helping transgender people during the COVID-19 pandemic

30 March 2021
Fighting transphobia and violence one social media post at a time

30 March 2021
Transgender communities in Asia and the Pacific respond to COVID-19 through activism


UNDP United Nations Development Programme [to 3 Apr 2021]
Latest from News Centre
UNDP releases SDG Impact Standards for Bond Issuers
SDG Impact Standards are already being piloted in the market with New Development Bank’s (NDB) SDG bond issuance in China Interbank Bond Market earlier this month.
Posted on April 1, 2021

New UNDP study reveals the magnitude of limited debt relief eligibility for developing economies
Two-thirds of external ‘debt service at risk’ is not covered by current relief initiatives, putting at risk years of progress on poverty and the future resources needed to deal with climate change
Posted on April 1, 2021


UNESCO [to 3 Apr 2021]
Selected Latest News
No new digest content identified.


UNHCR Office of the United Nations High Commissioner for Refugees [to 3 Apr 2021]
Selected Announcements
News Comment: Six refugees among 137 killed in Niger’s recent attack
This news comment is attributable to Gillian Triggs, UNHCR’s Assistant High Commissioner for Protection
1 Apr 2021



News comment: UNHCR calls on Myanmar’s neighbours to protect people fleeing violence
This news comment is attributable to Gillian Triggs, UNHCR’s Assistant High Commissioner for Protection
31 Mar 2021



UNHCR alarmed at brutal attacks by insurgent armed group in Mozambique
30 Mar 2021



UNHCR rushing support and aid to Rohingya refugees affected by last week’s massive fire
30 Mar 2021



United Nations Chiefs urge donors to support record appeals for Syrians and the region
Joint OCHA/UNHCR/UNDP Press Release
29 Mar 2021


UNICEF [to 3 Apr 2021]
Selected press releases, news notes and statements
Press release 04/01/2021
Pre-pandemic data show 1 in 8 countries spends more on debt than on education, health and social protection combined – UNICEF
UNICEF is calling for the extension of debt service relief and debt restructuring so that countries – and their children – can bounce back

Press release 03/31/2021
Yemen receives 360,000 COVID-19 vaccine doses through the COVAX Facility
… The AstraZeneca vaccines licensed and manufactured by the Serum Institute of India will enable health workers and other priority populations vulnerable to COVID-19 to be protected against the virus…

Statement 03/30/2021
Statement by UNICEF Executive Director Henrietta Fore on killing of polio workers in Afghanistan
[See Polio above for detail]

Press release 03/30/2021
UNICEF fund aims to raise US$2.5 billion for COVID-19 health supplies; low- and middle-income countries set to benefit
Denmark makes first donation to support the global equitable access to COVID-19 tests, treatments and vaccines
[See COVID above for detail]

Statement 03/29/2021
UNICEF Executive Director Henrietta Fore’s remarks at the World Immunisation & Logistics Summit, hosted by the HOPE Consortium


Unitaid [to 3 Apr 2021]
Featured News
31 March 2021
Unitaid statement regarding Ivermectin as a potential COVID-19 treatment
Geneva – Ivermectin, as well as other repurposed and new products, has been under evaluation in clinical trials as a potential treatment for COVID-19.
After updating the independent living network meta-analysis, the WHO Guidelines Development Group has updated the WHO Living Guidelines: Therapeutics and COVID-19 (today March 31).  In this updated version, WHO recommends not to use ivermectin in patients with COVID-19 except in the context of clinical trials based on very low certainty of evidence.
Unitaid, in collaboration with the University of Liverpool, has tracked the evidence available for ivermectin from randomised clinical studies from around the world, with various studies still to be completed.
In addition, to support the acquisition of the necessary remaining evidence as soon as possible, the ANTICOV consortium – coordinated by DNDi and partly funded by Unitaid – is preparing to add ivermectin in a combination therapy, as a new treatment arm to the clinical trial. This large platform trial aims to identify treatments that can be used to treat mild and moderate cases of COVID-19, preventing them from progressing to severe COVID-19, and is being conducted in 13 countries in Africa, nine of which are funded by Unitaid.”


Vaccination Acceptance Research Network (VARN) [to 3 Apr 2021]
No new digest content identified.


Vaccine Confidence Project [to 3 Apr 2021]
News, Research and Reports
Coronavirus global impact
Launched April 2, 2020 and recurring every 3 days, Premise Data is utilizing its global network of Contributors to assess economic, social, and health sentiment surrounding the coronavirus (COVID-19).


Vaccine Education Center – Children’s Hospital of Philadelphia [to 3 Apr 2021]
No new digest content identified.


Wellcome Trust [to 3 Apr 2021]
News and reports
Why is a global Covid-19 vaccine rollout vital?
30 March 2021

Our new funding will support bold and creative discovery research to improve health
29 March 2021
Michael Dunn shares more information about our new discovery research funding schemes, and the role of the Discovery Research team in Wellcome’s new strategy.


The Wistar Institute [to 3 Apr 2021]
Press Releases
Apr. 1, 2021
Wistar Scientists Discover New Mechanism Through Which Senescent Cells Turn On Genes That Encode for Secreted Tumor-regulating Factors
New insights into expression of the senescence-associated secretory phenotype.


WFPHA: World Federation of Public Health Associations [to 3 Apr 2021]
Latest News
Stop Blocking the Scale-up of Vaccines and Put Health over Profit!
Mar 31, 2021
On the occasion of World Health Day, WFPHA has joined a broad coalition of civil society organisations across Europe urgently calling on governments and EU institutions to implement a COVID-19 response based on global solidarity and to act to ensure that COVID-19 vaccines and medical products are available to everyone, everywhere in the world by waiving intellectual property rights (IPR) and sharing know-how and technology widely.


World Bank [to 3 Apr 2021]
Selected News, Announcements
Event – COVID-19: Vaccines for Developing Countries
Friday, April 9th | 11:00 am ET
The rollout of COVID-19 vaccines in developing countries is critical to protecting lives, building human capital, and stimulating economic recovery. The current crisis is exacerbating inequalities throughout the world and, without access to vaccines, the gap will widen further. Ensuring developing countries can access, as well as safely distribute vaccines, calls for strong partnership and cooperation at the national, regional & global levels. This event will explore:
:: The work underway in developing countries to prepare for large scale vaccine rollouts; the strengths and gaps in country readiness; measures to ensure access and distribution; and the importance of partnerships and cooperation across all stakeholders for success.
:: The private sector’s essential role in driving innovation, production and manufacturing to meet the enormous needs for COVID-19 vaccines, tests and therapeutics.
:: Taking a broad view of COVID-19 to reflect on opportunities and challenges across research, finance and policy, as we work to build more resilient health and economic systems now –and in the future.

Government of Nepal and World Bank sign $75 million additional financing agreement for COVID-19 vaccines
KATHMANDU, April 2, 2021 – The Government of Nepal and the World Bank today signed an agreement for additional financing of $75 million to support access to safe and effective COVID-19 vaccines for…
Date: April 02, 2021 Type: Press Release

WBG Vaccine Announcement– Key Facts
COVID-19 vaccines, alongside widespread testing, improved treatment and strong health systems are critical to save lives and strengthen the global economic recovery. To provide relief for vulnerable populations…
Date: March 30, 2021 Type: Factsheet


World Customs Organization – WCO [to 3 Apr 2021]
Latest News – Selected Items
30 March 2021
COVID-19 vaccine awareness: WCO completes three series of webinars involving the private sector
The World Customs Organization (WCO) successfully carried out three series of webinars between late January and late March 2021, to raise awareness about COVID-19 vaccines. The first series of webinars was held from 21 to 28 January in collaboration with Pfizer, the second from 15 to 17 March with Moderna, and the third one on 24 and 25 March with AstraZeneca.
The 11 webinars, which brought together more than 1,300 participants in total, focused on the essential specifications of COVID-19 vaccines as well as details of their distribution patterns, the aim being to make Customs better equipped to identify counterfeit or sub-standard COVID-19 vaccines at borders and curb trafficking, notably during this important period of COVID-19 vaccine delivery to governments…


World Organisation for Animal Health (OIE) [to 3 Apr 2021]
Press Releases
No new digest content identified.


WTO – World Trade Organisation [to 3 Apr 2021]
WTO News and Events
World trade primed for strong but uneven recovery after COVID-19 pandemic shock
31 March 2021
Prospects for a quick recovery in world trade have improved as merchandise trade expanded more rapidly than expected in the second half of last year. According to new estimates from the WTO, the volume of world merchandise trade is expected to increase by 8.0% in 2021 after having fallen 5.3% in 2020, continuing its rebound from the pandemic-induced collapse that bottomed out in the second quarter of last year.





ARM [Alliance for Regenerative Medicine] [to 3 Apr 2021]
Press Releases – Alliance for Regenerative Medicine (
Press Releases
No new digest content identified.


BIO [to 3 Apr 2021]
Press Releases
No new digest content identified.


DCVMN – Developing Country Vaccine Manufacturers Network [to 3 Apr 2021]
News; Upcoming events
No new digest content identified.


ICBA – International Council of Biotechnology Associations [to 3 Apr 2021]
No new digest content identified.


IFPMA [to 3 Apr 2021]
Selected Press Releases, Statements, Publications
COVID-19 vaccine and treatment innovators response to global leaders urgent call for international pandemic treaty
30 March 2021 –
[See Milestones above for detail]

Identification & Traceability of Medicinal Products – A tool towards strengthening health systems
30 March 2021


PhRMA [to 3 Apr 2021]
Selected Press Releases, Statements
Strengthening a culture dedicated to patients and equity: A conversation with Vas Narasimhan, CEO of Novartis
March 31, 2021
Strengthening a culture dedicated to patients and equity: A conversation with Vas Narasimhan, CEO of Novartis